MEDDIC vs Challenger vs SPIN vs Sandler: which methodology fits your team?
They answer different questions
The four big methodologies are often treated as rivals; they mostly aren't, because they operate at different layers. MEDDIC is a qualification framework (is this deal real?). Challenger is a selling posture (how do we differentiate?). SPIN is a questioning discipline (how do we build urgency?). Sandler is a full process system (how do we control the sale end to end?).
Quick comparison
- MEDDIC — best for: enterprise deals with long cycles and many stakeholders; optimises forecast accuracy; weakness: doesn't teach selling
- Challenger — best for: competitive, commoditising markets where insight differentiates; optimises win rate vs status quo; weakness: hard to coach at scale
- SPIN — best for: consultative sales where urgency must be built; optimises conversation quality; weakness: light on process control
- Sandler — best for: teams drowning in unqualified proposals; optimises pipeline honesty; weakness: culture shift takes real training investment
How they combine
The most common working stack in B2B software: SPIN or Challenger as the conversational motion, MEDDIC as the qualification and inspection layer on top. Sandler tends to be adopted whole, as an operating system, rather than mixed.
Whichever you run, the leadership question is the same: is the methodology actually applied on live deals, or does it live in a training binder? That's an inspection problem — and it's the problem SaleSonicAI is built to solve, by scoring every deal and forecast against the methodology set in your Commercial DNA.
Choosing, pragmatically
Pick based on your failure mode. Deals slipping at the end of quarter → MEDDIC. Losing to 'do nothing' or cheaper rivals → Challenger. Pipelines full of polite interest → SPIN. Proposal-heavy, close-light teams → Sandler.
Then make it stick: one methodology, scored on every deal, visible in every forecast review. Tooling helps; consistency wins.